Trial Profile
Effect of tacrolimus for patients with refractory Crohn's disease: A randomized, placebo-controlled trial.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 30 Dec 2013 Planned End Date changed from 1 Nov 2011 to 31 Dec 2015 as reported by University Hospital Medical Information Network - Japan.
- 17 Dec 2009 Planned end date (1 Nov 2011) added as reported by University Hospital Medical Information Network - Japan.
- 30 Nov 2009 New trial record